A detailed history of Bailard, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Bailard, Inc. holds 69,459 shares of ZTS stock, worth $11.5 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
69,459
Previous 68,735 1.05%
Holding current value
$11.5 Million
Previous $11.9 Million 13.89%
% of portfolio
0.36%
Previous 0.33%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$172.58 - $196.48 $124,947 - $142,251
724 Added 1.05%
69,459 $13.6 Million
Q2 2024

Jul 25, 2024

BUY
$145.54 - $178.83 $94,455 - $116,060
649 Added 0.95%
68,735 $11.9 Million
Q1 2024

May 08, 2024

BUY
$165.67 - $199.94 $994 - $1,199
6 Added 0.01%
68,086 $11.5 Million
Q4 2023

Feb 02, 2024

BUY
$151.44 - $200.09 $1.89 Million - $2.5 Million
12,511 Added 22.51%
68,080 $13.4 Million
Q3 2023

Oct 24, 2023

BUY
$167.14 - $192.77 $388,600 - $448,190
2,325 Added 4.37%
55,569 $9.67 Million
Q2 2023

Jul 20, 2023

SELL
$160.94 - $186.23 $402,671 - $465,947
-2,502 Reduced 4.49%
53,244 $9.17 Million
Q4 2022

Feb 02, 2023

SELL
$131.14 - $157.47 $786 - $944
-6 Reduced 0.01%
55,746 $8.17 Million
Q3 2022

Oct 18, 2022

SELL
$148.29 - $182.55 $29,658 - $36,510
-200 Reduced 0.36%
55,752 $8.27 Million
Q2 2022

Jul 27, 2022

SELL
$155.97 - $200.09 $5,147 - $6,602
-33 Reduced 0.06%
55,952 $9.62 Million
Q4 2021

Feb 10, 2022

BUY
$193.69 - $247.03 $27,503 - $35,078
142 Added 0.25%
55,985 $13.7 Million
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $37,858 - $41,938
200 Added 0.36%
55,843 $10.8 Million
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $8.01 Million - $9.43 Million
55,643 New
55,643 $8.76 Million
Q3 2020

Nov 10, 2020

SELL
$137.1 - $165.37 $200,714 - $242,101
-1,464 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$111.92 - $142.53 $163,850 - $208,663
1,464 New
1,464 $201,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.